Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKZF1 | Q13422 | 5/20 | 0.65 |
| ▸ | IKZF2 | Q9UKS7 | 8/20 | 0.56 |
| ▸ | CRBN | Q96SW2 | 5/20 | 0.50 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.50 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.50 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.50 |
| ▸ | WIZ | O95785 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31338387 | 0.86 | IKZF1 (0.69) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338117 | 0.86 | IKZF1 (0.64) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338029 | 0.86 | IKZF1 (0.71) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338094 | 0.86 | IKZF1 (0.51) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338054 | 0.85 | IKZF1 (0.65) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338316 | 0.83 | IKZF1 (0.69) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338241 | 0.83 | IKZF2 (0.56) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338081 | 0.83 | IKZF2 (0.62) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31338399 | 0.82 | IKZF1 (0.70) | IKZF1IKZF2CRBNGSPT1DDB1 | |
| SCHEMBL31279761 | 0.82 | IKZF1 (0.42) | IKZF1IKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745137-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| WO-2025016359-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | 标新生物医药科技(上海)有限公司 | 2025-01-23 | — | — | WO | claimed |
| EP-4745137-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025016359-A1 | GLUTARIMIDE ISOINDOLINONE SKELETON-BASED COMPOUND | 标新生物医药科技(上海)有限公司 | 2025-01-23 | — | — | WO | disclosed |